Page 1 of 1

Tailong Pharmaceutical, North China Pharmaceutical

Posted: Mon Feb 17, 2025 9:49 am
by Rina7RS
Luoxins Pharmaceutical, Baihua Pharmaceutical, Xinhua Pharmaceutical, Lu'an Pharmaceutical, Northeast Pharmaceutical, Yiling Pharmaceutical, Huluwa, Zhongsheng Pharmaceutical, Harbin Pharmaceutical Group, and Peking University Pharmaceutical rising by the daily limit, Hualan Vaccine, Shuanglu Pharmaceutical, and Shenqi Pharmaceutical rising by more than , Jinghua Pharmaceutical, Hongri Pharmaceutical, and Guangdong Evergreen rising by more than .

It is winter now and influenza A has struck again, so influenza drugs are attracting attention. Some media reported that Roche's influenza treatment drug Sufoda was out of stock in many drugstore chains and macedonia phone number list that prices had increased in offline drugstores. On January , Roche China responded that this year the company attached great importance to the supply of Sufuda and the current market supply is sufficient.

The minor metal sector strengthened, Guangsheng Nonferrous Metals hit the daily limit, China Rare Earth and Shenghe Resources rose by more than .

The special steel sector rose sharply, Ma Steel shares hit the daily limit, Fu'an Co., Ltd. and Wangbian Electric rose more than , Hangzhou Iron & Steel Co., Ltd. rose more than , and Guangda Special Materials and Yongxing Materials rose more than .

The rare earth permanent magnet sector performed actively, with Galaxy Magnet rising more than , XMagnetics Technology rising more than , Innova rising more than , and China Rare Earth rising more than .